Brucella melitensis clinical isolate modulates osteoclast differentiation to drive pathological bone destruction in

Jinlei Chen1,2,3,4, Feijie Zhi2,3,4, Guanghai Zhao1

  • 1Orthopedics Key Laboratory of Gansu Province, Department of Orthopedics, The Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.

Abstract

Insights

Brucella melitensis directly infects and targets osteoclasts, leading to prolonged survival and bone destruction in brucellar arthritis. This interaction explains the high prevalence of this disabling complication of brucellosis.

Area of Science:

  • Microbiology
  • Immunology
  • Bone Biology

Background:

  • Brucellosis is a zoonotic disease with articular complications like brucellar spondylitis.
  • Osteoclast activation is implicated in Brucella-induced bone destruction, but bacterial tropism and effects on osteoclasts are unclear.

Purpose of the Study:

  • Characterize the osteoclast tropism of Brucella melitensis biovar 3 clinical isolates.
  • Investigate direct regulatory effects on osteoclast-mediated bone destruction in brucellar arthritis.

Main Methods:

  • Obtained Brucella clinical isolates from human spondylitis patients.
  • Used whole-genome sequencing, biotyping, and mouse models.
  • Assessed cellular tropism and osteoclast effects via various in vitro and in vivo assays.

Main Results:

  • Identified B. melitensis biovar 3 isolates with genomic homology to Chinese strains.
  • Demonstrated strong tropism for human and murine osteoclasts over osteoblasts/osteocytes.
  • Showed infection enhances osteoclastogenesis, inhibits apoptosis, prolongs survival, and increases bone resorption.

Conclusions:

  • Elucidated mechanisms of bone defects in brucellar arthritis.
  • Highlighted osteoclast-derived pro-survival niche in chronic brucellosis.
  • Proposed targeting B. melitensis-osteoclast interaction as a therapeutic strategy.